Author： Slassi Abdelmalik Isaac Methvin O’Brien Anne
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.4, 2002-04, pp. : 513-527
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
In light of the barrage of recent reviews on 5-HT6 receptor antagonists, this article highlights and reviews the research advances published in patent literature between January 1998 and December 2001. The article is supplemented with selected references on design, synthesis and development of novel 5-HT6 agents to treat CNS diseases and to study and understand their mechanism and pathophysiology. Emphasis is given to recent advances in the possible involvement of 5-HT6 serotonergic agents in the treatment of schizophrenia and depression. By no means has any attempt been made to exhaustively review the literature but rather, primary references along with citations to recent literature reviews have been included in each section.
Related content
Access to resources
Recommend
